Encorafenib, Binimetinib and Palbociclib in BRAF-mutant Metastatic Melanoma CELEBRATE

NCT04720768 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

78

Enrollment

OTHER

Sponsor class

Conditions

Melanoma
Metastasis

Interventions

DRUG: Binimetinib
DRUG: Encorafenib
DRUG: Palbociclib

Sponsor

Peter MacCallum Cancer Centre, Australia